FrancophonIA/ELRC3.0 huggingface dataset:
English: EXPIRY DATE [For terms on Batch number and Expiry date see Appendix IV on the European Medicines Agency website http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/201 4/08/WC500170559.pdf] http://www.emea.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/20 09/10/WC500004426.pdf]
Slovenian: DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA [For terms on Batch number and Expiry date see Appendix IV on the European Medicines Agency website http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/201 4/08/WC500170559.pdf] http://www.emea.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/200 9/10/WC500004426.pdf]
English: <Specific pharmacovigilance requirements:>
Slovenian: <POGOJNEGA DOVOLJENJA ZA PROMET Z ZDRAVILOM> <DOVOLJENJA ZA
English: <MANUFACTURER<S> OF THE BIOLOGICAL ACTIVE SUBSTANCE<S> AND>
Slovenian: <učinki>, <toksični učinki na mater.>>
English: <For any information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder.
Slovenian: DRUGE INFORMACIJE> < Ni nujno, da so v prometu vsa navedena pakiranja.> <Za vse nadaljnje informacije o tem zdravilu se obrnite na krajevno predstavništvo imetnika dovoljenja za promet z zdravilom.>
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS {NATURE/TYPE}
Slovenian: PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH
English: <Personal protective equipment consisting of {specify} should be worn when handling the veterinary medicinal product.>
Slovenian: <Pri ravnanju z zdravilom nosite osebno zaščitno opremo, ki sestoji iz {opredelite}.> < Tega zdravila naj ne dajejo nosečnice.>
English: <The excipients listed in section 6.1 of the SPC are <either> <allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required> <or> <considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product>.>
Slovenian: za katere tabela 1 (dovoljene snovi) priloge Uredbe Komisije (EU) št. 37/2010 določa, da MRL ni potreben> <ali pa,> <ne spadajo v področje uporabe Uredbe (ES) št. 470/2009, kadar kot so uporabljene tako kot v tem zdravilu za uporabo v veterinarski medicini, niso vključene v Uredbo(ES) št. 470/2009>.>
English: 4.6 Adverse reactions (frequency and seriousness)
Slovenian: Neželeni učinki (pogostost in resnost) <Pogostost neželenih učinkov je določena po naslednjem dogovoru:
English: SPECIAL WARNING(S) <None.>
Slovenian: POSEBNO(A) OPOZORILO(A), ČE JE/SO POTREBNO(A)
English: PACKAGE LEAFLET FOR: {(Invented) name of veterinary medicinal product <strength> pharmaceutical form <target species>}
Slovenian: NAVODILO ZA UPORABO {(Izmišljeno) ime zdravila <jakost> farmacevtska oblika <ciljne živalske vrste>}
English: <Pregnancy:> <and lactation:>
Slovenian: KARENCA <Karenca:>
English: <In case of accidental <self-administration><self-injection><ingestion><spillage onto skin>, seek medical advice immediately and show the package leaflet or the label to the physician.>
Slovenian: Posebni previdnostni ukrepi, ki jih mora izvajati oseba, ki živalim daje zdravilo <Ni smiselno.> <V primeru nenamerne(ga) <samo-aplikacije> <samo-injiciranja> <zaužitja> <razlitja po koži> se takoj posvetujte z zdravnikom in mu pokažite navodila za uporabo ali ovojnino.> <Osebe z znano preobčutljivostjo na {INN} naj se <se izogibajo stiku z zdravilom..> <zdravilo dajejo previdno.>> <Pri dajanju tega zdravila je potrebna previdnost.>
English: <Veterinary medicinal product subject to prescription.> <Veterinary medicinal product not subject to prescription.>
Slovenian: <Na veterinarski recept.> <Rp-Vet.> <Brez Rp-Vet.>
English: NAME OF THE VETERINARY MEDICINAL PRODUCT {(Invented) name of veterinary medicinal product <strength> pharmaceutical form<target species>} {active substance(s)}
Slovenian: IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI {(Izmišljeno) ime zdravila <jakost> farmacevtska oblika <ciljne živalske vrste>}}
English: <Keep the {container}**** tightly closed > <Keep the {container}**** in the outer carton > <in order to protect from <light> <and> <moisture>.>
Slovenian: <{Vsebnik} shranjujte**** tesno zaprt.> <{Vsebnik} shranjujte****v zunanji ovojnini.>
English: <Keep the {container}**** tightly closed> <Keep the {container}**** in the outer carton> <in order to protect from <light> <and> <moisture>.>
Slovenian: <{Vsebnik} shranjujte ****tesno zaprt.> <{Vsebnik} shranjujte ****v zunanji ovojnini.>
English: WITHDRAWAL PERIOD(S) <Withdrawal period(s): >
Slovenian: <Rok uporabnosti po <razredčenju> <rekonstituciji> v skladu z navodili: >
English: <SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR THE MARKETING AUTHORISATION UNDER EXCEPTIONAL CIRCUMSTANCES>
Slovenian: PROMET Z ZDRAVILOM V IZJEMNIH OKOLIŠČINAH>> <Ker gre za odobritev v izjemnih okoliščinah in ob upoštevanju člena 39.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT {(Invented) name of veterinary medicinal product <strength> pharmaceutical form <target species>}
Slovenian: IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI {(Izmišljeno) ime zdravila jakost> farmacevtska oblika <ciljne živalske vrste>}
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance
: <Adjuvant
:> <Excipient
:>
Slovenian: Zdravilna(e) Uučinkovina(e): <Dodatek(dodatki):> <Pomožna(pomožne) snov(i):> Za celoten seznam pomožnih snovi, glejte poglavje 6.1.
English: <Medicines should not be disposed of via wastewater or <household waste>.> <Ask your <veterinary surgeon> <or> <pharmacist> how to dispose of medicines no longer required.
Slovenian: <Ne odvrzite zdravila v odpadno vodo ali <vmed gospodinjske odpadke>.>
English: OTHER INFORMATION>
Slovenian: <Okoljski podatki>
English: <Keep the {container}**** in the outer carton> <Keep the {container}**** tightly closed> <in order to protect from <light> <and> <moisture>.>
Slovenian: <{Vsebnik}**** shranjujte v zunanji ovojnini.> <{Vsebnik}**** shranjujte tesno zaprt.>
English: PARTICULARS TO APPEAR ON <THE OUTER PACKAGE> <AND> <THE IMMEDIATE PACKAGE>
Slovenian: <PODATKI NA <ZUNANJI OVOJNINI> <IN> <STIČNI OZ. PRIMARNI OVOJNINI>
English: {Name and aAddress Country} <{Tel.}> <{Fax}> <{E-mail}>
Slovenian: {Ime in nNaslov Država} <{Tel}> <{Faks}> <{E-pošta}>
English: The CVMP therefore recommends a variation of the Marketing Authorisation.
Slovenian: CVMP zato priporoča spremembo dovoljenja za promet z zdravilom.
English: The CVMP considers that based on all available data, there is no concern regarding safety or efficacy for the product.
Slovenian: Odbor za zdravila za uporabo v veterinarski medicini (CVMP) meni, da na osnovi razpoložljivih podatkov ni zadržkov glede varnosti ali učinkovitosti izdelka.
English: Animal species
Slovenian: Ciljne živalske vrste
English: • The batches are formulated with a fixed quantity of bacteria, quantified using an approved and validated method.
Slovenian: • Se serije oblikujejo z ustaljeno količino bakterij, ki jo odmerijo z odobreno in potrjeno metodo.
English: However, it is important to ensure that the pass limits of the potency test do not drift from the original.
Slovenian: Kljub temu je pomembno zagotoviti, da se meje sprejemljivosti pri testu učinkovitosti ne oddaljijo od prvotnih meja.
English: • The potencies of the two reference batches (9097 and 9861) are higher than the PEI reference serum and the reference vaccine batch 8500.
Slovenian: • Učinkovitosti obeh referenčnih serij (9097 in 9861) sta večji od referenčnega seruma PEI in serije referenčnega cepiva 8500.
English: Frequency and route of administration
Slovenian: Odmerjanje in pot uporabe
English: The reference vaccine changes included in this referral relate to the replacement of batch 8500 with 9097 and the subsequent replacement of batch 9097 with 9861.
Slovenian: Spremembe referenčnega cepiva v tem zaključku se nanašajo na zamenjavo serije cepiva 8500 s serijo 9097 in naknadno zamenjavo serije 9097 s serijo 9861.
English: During assessment of a Type II variation for changing the mouse potency test to comply with the revised Ph.Eur monograph for erysipelas vaccines, vaccine batch 8500 was accepted as being a reference vaccine and therefore this batch and those prior to it have to be accepted as being compliant with the conditions of the Marketing Authorisations for both products.
Slovenian: Med ocenjevanjem variacije tipa II za spremembo testa farmakološke učinkovitosti pri miših, da bi ta ustrezal popravljeni monografiji Evropske farmakopeje (Ph.Eur) za cepiva proti erizipelu, je bila kot referenčno cepivo sprejeta serija cepiva 8500, zaradi česar je treba to serijo in tiste pred njo sprejeti kot skladne s pogoji dovoljenja za promet z zdravilom za oba izdelka.
English: Issues that related to the equivalence of reference vaccine batches arose during subsequent variations.
Slovenian: Vprašanja glede enakovrednosti različnih serij referenčnega cepiva so se pojavila pri kasnejših variacijah.
English: In both cases the Marketing Authorisation Holder (MAH) has shown that these batches qualify as reference vaccine batches because
Slovenian: V obeh primerih je imetnik dovoljenja za promet z zdravilom pokazal, da so omenjene serije primerne kot referenčno cepivo, ker:
English: However, the submitted data demonstrated large variability in the test results of the reference batches in the serological potency test.
Slovenian: Vendar pa so predstavljeni podatki pokazali velike razlike med rezultati testov na referenčnih serijah pri testu serološke učinkovitosti.
English: • The batches were commercial batches manufactured to the production methods and specification described in the MA.
Slovenian: • So bile te serije za komercialne namene in izdelane s postopki izdelave in specifikacijami, ki so opisane v dovoljenju za promet z zdravilom.
English: ANNEX I NAME, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCTS, ANIMAL SPECIES, ROUTES OF ADMINISTRATION, AND MARKETING AUTHORISATION HOLDER
Slovenian: IME, FARMACEVTSKA OBLIKA, JAKOST, CILJNA ŽIVALSKA VRSTA, NAČIN UPORABE ZDRAVILA , IMETNIK(I) DOVOLJENJ(A) ZA PROMET
English: • The batches passed the test for target animal safety according to Ph. Eur monograph 0064.
Slovenian: • So serije prestale test varnosti pri ciljnih živalih v skladu z monografijo Evropske farmakopeje
English: This was explained as an inherent variability in the in-vivo part of the test, because of variability between batches of mice.
Slovenian: Raznolikost rezultatov so v razlagi opisali kot neločljivo povezano z in-vivo delom testa, zaradi razlik med serijami miši.
English: This variability reduced the ability of the test to demonstrate equivalence between reference batches.
Slovenian: Zaradi te raznolikosti je zmožnost testa pokazati enakovrednost različnih referenčnih serij zmanjšana.
English: potency test in pigs at 1/3 dose, which provides evidence of target animal efficacy.
Slovenian: odmerka, kar dokazuje učinkovitost pri ciljnih živalih.
English: Recommended dose
Slovenian: Priporoc(en odmerek
English: • The MAH followed the correct SOP for replacement at the time the replacements were made.
Slovenian: • Imetnik dovoljenja za promet z zdravilom je pri zamenjavah upošteval ustrezne standardne delovne postopke za zamenjavo.
English: Date of first authorisation: 23 September 2009 Date of latest renewal: 22 May 2014
Slovenian: Datum prve odobritve: 23. september 2009 Datum zadnjega podaljšanja: 22. maj 2014
English: - Your doctor may order blood tests.
Slovenian: - lahko vaš zdravnik naroči krvne preiskave.
English: An occasional use of acetylsalicylic acid (no more than 1000 mg in any 24 hour period) should generally not cause a problem, but prolonged use in other circumstances should be discussed with your doctor.
Slovenian: Priložnostna uporaba acetilsalicilne kisline (ne več kot 1000 mg v kateremkoli 24-urnem obdobju) na splošno ne bi smela povzročati težav, vendar pa se morate o daljši uporabi v drugih okoliščinah posvetovati s svojim zdravnikom.
English: Their frequency is defined using the following conventions: common (1/100 to <1/10); uncommon (1/1,000 to <1/100); rare (1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data).
Slovenian: Njihova pogostnost je navedena po naslednjem dogovoru: pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000), neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
English: Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Slovenian: Pred začetkom jemanjazdravila natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
English: While you are taking Clopidogrel TAD: - You should tell your doctor if a surgery (including dental) is planned.
Slovenian: Ko jemljete zdravilo Klopidogrel TAD: - morate zdravniku povedati, če imate predvideno kakšno operacijo (tudi zobozdravstveni poseg).
English: 7 film-coated tablets: EU/1/09/555/001 14 film-coated tablets: EU/1/09/555/002 28 film-coated tablets: EU/1/09/555/003 30 film-coated tablets: EU/1/09/555/004 50 film-coated tablets: EU/1/09/555/005 56 film-coated tablets: EU/1/09/555/006 84 film-coated tablets: EU/1/09/555/007 90 film-coated tablets: EU/1/09/555/008 100 film-coated tablets: EU/1/09/555/009
Slovenian: 7 filmsko obloženih tablet: EU/1/09/555/001 14 filmsko obloženih tablet: EU/1/09/555/002 28 filmsko obloženih tablet: EU/1/09/555/003 30 filmsko obloženih tablet: EU/1/09/555/004 50 filmsko obloženih tablet: EU/1/09/555/005 56 filmsko obloženih tablet: EU/1/09/555/006 84 filmsko obloženih tablet: EU/1/09/555/007 90 filmsko obloženih tablet: EU/1/09/555/008 100 filmsko obloženih tablet: EU/1/09/555/009
English: Some other medicines may influence the use of Clopidogrel TAD or vice versa.
Slovenian: Nekatera druga zdravila lahko vplivajo na jemanje zdravila Klopidogrel TAD in obratno.
English: Clopidogrel TAD 75 mg
Slovenian: Klopidogrel TAD 75 mg
English: What you need to know before you take Clopidogrel TAD
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Klopidogrel TAD
English: If you experience prolonged bleeding when taking Clopidogrel TAD If you cut or injure yourself, it may take longer than usual for bleeding to stop.
Slovenian: Če doživite podaljšanje krvavitve v času jemanja zdravila Klopidogrel TAD Če se urežete ali poškodujete, lahko traja dlje kot običajno, da se krvavitev ustavi.
English: You should have been told that ‘oral anticoagulants' are more effective than acetylsalicylic acid or the combined use of Clopidogrel TAD and acetylsalicylic acid for this condition.
Slovenian: Povedati so vam morali, da so "peroralni antikoagulanti" pri tej motnji učinkovitejši kot acetilsalicilna kislina ali kombinirana uporaba zdravila Klopidogrel TAD in acetilsalicilne kisline.
English: - If you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain.
Slovenian: - če imate zdravstveno stanje, ki trenutno povzroča krvavitev, npr. rana na želodcu ali možganska krvavitev.
English: Clopidogrel TAD with food and drink Clopidogrel TAD may be taken with or without food.
Slovenian: Zdravilo Clopidogrel TAD skupaj s hrano in pijačo Zdravilo Clopidogrel TAD lahko jemljete s hrano ali brez nje.
English: You should take Clopidogrel TAD for as long as your doctor continues to prescribe it.
Slovenian: Zdravilo Klopidogrel TAD morate jemati, dokler vam ga vaš zdravnik predpisuje.
English: Other medicines and Clopidogrel TAD
Slovenian: Druga zdravila in zdravilo Klopidogrel TAD
English: Your doctor should have prescribed Clopidogrel TAD plus acetylsalicylic acid if you cannot take ‘oral anticoagulants' and you do not have a risk of major bleeding.
Slovenian: Zdravnik naj bi vam predpisal zdravilo Klopidogrel TAD skupaj z acetilsalicilno kislino, če ne morete prejemati "peroralnih antikoagulantov", ali če nimate tveganja za večjo krvavitev.
English: If you take more Clopidogrel TAD than you should Contact your doctor or the nearest hospital emergency department because of the increased risk of bleeding.
Slovenian: Če ste vzeli večji odmerek zdravila Klopidogrel TAD, kot bi smeli Zaradi povečanega tveganja za krvavitev se posvetujte s svojim zdravnikom ali z medicinskim osebjem na najbližjem bolnišničnem oddelku za nujno zdravniško pomoč.
English: What Clopidogrel TAD looks like and contents of the pack The film-coated tablets are pink, round and slightly convex.
Slovenian: Izgled zdravila Klopidogrel TAD in vsebina pakiranja Filmsko obložente tablete so rožnate, okrogle in rahlo izbočene.
English: If you forget to take Clopidogrel TAD
Slovenian: Če ste pozabili vzeti zdravilo Klopidogrel TAD
English: If you think any of these apply to you, or if you are in any doubt at all, consult your doctor before taking Clopidogrel TAD.
Slovenian: Če menite, da se karkoli od navedenega nanaša na vas, ali če ste kakorkoli v dvomih, se posvetujte s svojim zdravnikom, preden vzamete zdravilo Klopidogrel TAD.
English: If you have experienced severe chest pain (unstable angina or heart attack), you may be prescribed Clopidogrel TAD in combination with acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever.
Slovenian: Če ste doživeli hudo bolečino v prsih (nestabilna angina pektoris ali srčni napad), so vam morda predpisali zdravilo Klopidogrel TAD v kombinaciji z acetilsalicilno kislino, učinkovino, ki je prisotna v številnih zdravilih, ki se uporabljajo za lajšanje bolečine in zniževanje zvišane telesne temperature.
English: Then, the recommended dose is one 75 mg tablet of Clopidogrel TAD per day as described above.
Slovenian: Nato je priporočeni odmerek ena 75-mg tableta zdravila Klopidogrel TAD na dan, kot je opisano zgoraj.
English: You have been prescribed Clopidogrel TAD to help prevent blood clots and reduce the risk of these severe events because: - You have a condition of hardening of arteries (also known as atherosclerosis), and - You have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease, or - You have experienced a severe type of chest pain known as ‘unstable angina' or ‘myocardial infarction' (heart attack).
Slovenian: Zdravilo Klopidogrel TAD vam je predpisano za pomoč pri preprečevanju nastajanja krvnih strdkov in za zmanjšanje tveganja teh hudih dogodkov, ker: - imate otrdele arterije (znano tudi kot ateroskleroza) in - ste predhodno doživeli srčni napad, kap ali imeli stanje, ki je znano kot periferna arterijska bolezen ali - ste doživeli hudo obliko bolečine v prsih, znano kot “nestabilna angina” ali “miokardni infarkt” (srčni napad).
English: Driving and using machines Clopidogrel TAD is unlikely to affect your ability to drive or to use machines.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Ni verjetno, da bi zdravilo Klopidogrel TAD vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
English: - If you are allergic to clopidogrel or any of the other ingredients of this medicine (listed in section 6).
Slovenian: Ne jemljite zdravila Klopidogrel TAD - če ste alergični na klopidogrel ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
English: If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist before taking Clopidogrel TAD.
Slovenian: Če ste noseči ali mislite, da ste noseči, morate o tem obvestiti svojega zdravnika ali farmacevta, preden vzamete zdravilo Klopidogrel TAD.
English: If you become pregnant while taking Clopidogrel TAD, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant.
Slovenian: Če med zdravljenjem z zdravilom Klopidogrel TAD zanosite, se takoj posvetujte s svojim zdravnikom, saj jemanje klopidogrela med nosečnostjo ni priporočljivo.
English: Boxes of 7, 14, 28, 30, 50, 56, 84, 90 and 100 film-coated tablets in blisters are available.
Slovenian: Na voljo so v pretisnih omotih po 7, 14, 28, 30, 50, 56, 84, 90 in 100 filmsko obloženih tablet v škatli.
English: - carbamazepine a medicine to treat some forms of epilepsy, - moclobemide, medicine to treat depression, - repaglinide, medicine to treat diabetes, - paclitaxel, medicine to treat cancer, - anti-retroviral medicines (medicines to treat HIV infections).
Slovenian: - efavirenz, zdravilo za zdravljenje infekcij z virusom HIV (virus humane imunske pomanjkljivosti), - karbamazepin, zdravilo za zdravljenje nekaterih oblik epilepsije, - moklobemid, zdravila za zdravljenje depresije, - repaglinid, zdravilo za zdravljenje sladkorne bolezni, - paklitaksel, zdravilo za zdravljenje raka, - protiretrovirusna zdravila (zdravila za zdravljenje okužbe z virusom HIV).
English: The recommended dose, including for patients with a condition called ‘atrial fibrillation' (an irregular heartbeat), is one 75 mg tablet of Clopidogrel TAD per day to be taken orally with or without food, and at the same time each day.
Slovenian: Priporočeni odmerek, vključno za bolnike, ki imajo bolezensko stanje, imenovano "atrijska fibrilacija" (nepravilen srčni utrip), je ena 75 mg tableta zdravila Klopidogrel TAD na dan, ki jo lahko vzamete s hrano ali brez nje; odmerek morate jemati vsak dan ob istem času.
English: Ask your doctor or pharmacist for advice before taking any medicine.
Slovenian: Posvetujete se z zdravnikom ali farmacevtom, preden vzamete katerokoli zdravilo
English: KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany
Slovenian: KRKA, d. d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija TAD Pharma GmbH, Heinz-Lohmann-Strasse 5, 27472 Cuxhaven, Nemčija
English: What Clopidogrel TAD is and what it is used for 2.
Slovenian: Kaj je zdravilo Klopidogrel TAD in za kaj ga uporabljamo
English: Do not use this medicine after the expiry date which is stated on the carton and blister after EXP.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in pretisnem omotu poleg oznake "EXP".Rok uporabnosti zdravila se izteče na zadnji dan navedenega meseca.
English: Do not stop the treatment unless your doctor tells you so.
Slovenian: Če ste prenehali jemati zdravilo Klopidogrel TAD Ne prekinite zdravljenja razen, če tako odloči zdravnik.
English: If you have experienced severe chest pain (unstable angina or heart attack), your doctor may give you 300 mg of Clopidogrel TAD (4 tablets of 75 mg) once at the start of treatment.
Slovenian: Če ste imeli hudo bolečino v prsih (nestabilna angina pektoris ali srčna kap), vam lahko zdravnik na začetku zdravljenja da enkrat 300 mg zdravila Klopidogrel TAD (štiri 75-mg tablete).
English: How to take Clopidogrel TAD
Slovenian: Kako jemati zdravilo Klopidogrel TAD